FDA OKs Emergency Use of MDx Swine Flu Test; CDC Recommends MDx Testing | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration yesterday authorized the emergency use of a molecular diagnostic assay to identify cases of swine flu.

The test has not been cleared for marketing by FDA, but the agency granted the US Centers for Disease Control and Prevention the authority to use the multiplex panel to diagnose patients in the US. The rRT-PCR Swine Flu Panel is currently available through a small number of government labs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.